JLK, Inc. (KOSDAQ:322510)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,590.00
+170.00 (2.29%)
Apr 29, 2026, 1:00 PM KST
6.01%
Market Cap 188.36B
Revenue (ttm) 3.34B
Net Income (ttm) -13.61B
Shares Out 25.39M
EPS (ttm) -540.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 523,658
Average Volume 308,842
Open 7,420.00
Previous Close 7,420.00
Day's Range 7,300.00 - 7,790.00
52-Week Range 3,965.00 - 9,210.00
Beta 1.68
RSI 57.99
Earnings Date May 13, 2026

About JLK, Inc.

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, ... [Read more]

Industry Conglomerates
Sector Industrials
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 322510
Full Company Profile

Financial Performance

In 2025, JLK, Inc.'s revenue was 3.34 billion, an increase of 133.94% compared to the previous year's 1.43 billion. Losses were -13.61 billion, 1.13% more than in 2024.

Financial Statements

News

There is no news available yet.